ID Biomedical Corporation, Quebec clinical trials
Acquired by GlaxoSmithKline
The registry lists 2 studies whose lead sponsor is ID Biomedical Corporation, Quebec. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 22, 2007.
- 2studies on the registry
- 0open to participants now
All 2 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed150%
- Status unknown or other150%
Registry sponsor names on this page
- ID Biomedical Corporation, Quebec2 studies
Something wrong with this grouping? Tell us on the GlaxoSmithKline page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All GlaxoSmithKline studies →
- Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and OverCompletedNCT00232947Phase 3
Sponsor listed in the registry: ID Biomedical Corporation, Quebec · ID Biomedical Corporation, Quebec — acquired company within the GlaxoSmithKline group
- Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o.Status unknownNCT00216242Phase 3
Sponsor listed in the registry: ID Biomedical Corporation, Quebec · ID Biomedical Corporation, Quebec — acquired company within the GlaxoSmithKline group